Posts Tagged :

Shields Care Model

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes 204 115 Shields Health Solutions

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes
Shields demonstrates its unwavering commitment to specialty patient care through our latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA), and multiple sclerosis (MS).
Impact of an Integrated Health System Specialty Pharmacy on HIV Clinical Outcomes 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy on HIV Clinical Outcomes

This poster highlights our collaboration with Proprium Pharmacy and how the HSSP model consistently improves HIV clinical outcomes, regardless of factors like age, gender, time on service, race/ethnicity, or insurance.…

Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies 216 115 Shields Health Solutions

Impact of Patient Assistance Programs on Out-of-Pocket Costs for Oral Oncolytics Managed Through Integrated Health System Specialty Pharmacies

This poster highlights the impact of an HSSP model on accessing Patient Assistance Program (PAP) funding for oral oncolytic drugs. Government-insured patients received PAP support more often with brand medications…

Clinical and Quality Outcomes of a Hypertrophic Cardiomyopathy Management Program within an Integrated Health System Specialty Pharmacy Model 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Hypertrophic Cardiomyopathy Management Program within an Integrated Health System Specialty Pharmacy Model

This poster spotlights our collaboration with NYULangone Health and highlights how the success of an ambulatory pharmacist-led program within an HSSP in efficiently handling mavacamten therapy and REMS program requirements…

Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Impact of an Ambulatory Clinical Pharmacist on Oral Oncolytics in a Hematology/Oncology Specialty Clinic Integrated with a Health System Specialty Pharmacy

This poster highlights the positive impact of introducing ACP services into a hematology/oncology clinic, leading to successful outcomes and substantial cost savings following HSSP integration. Challenges in cost estimation stemmed…

Implementation of Ambulatory Clinical Pharmacist Type 2 Diabetes Care Services Within an Integrated Health-System Specialty Pharmacy 216 115 Shields Health Solutions

Implementation of Ambulatory Clinical Pharmacist Type 2 Diabetes Care Services Within an Integrated Health-System Specialty Pharmacy

This poster spotlights our collaboration with NYULangone Health and highlights how the integration of ACP-let medication management services, specializing in diabetes care, into an integrated HSSP results in markedly improved…

Impact of Integrating a Pharmacy Liaison-Managed Care Model within a Diabetes Population 216 115 Shields Health Solutions

Impact of Integrating a Pharmacy Liaison-Managed Care Model within a Diabetes Population

This poster spotlights our collaboration with Berkshire Health Systems and highlights how implementing a pharmacy liaison-managed diabetes care model resulted in positive patient outcomes, including increased medication adherence, a 0.8%…

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes 204 115 Shields Health Solutions

Shields Health Solutions Consistently Demonstrates Superior Clinical Outcomes

STOUGHTON, Mass.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, recently published its latest patient outcomes in key disease states such as hepatitis C, HIV, rheumatoid arthritis (RA),…

PAH Care Model Provides a Road Map for Rare Disease Treatment 204 115 Shields Health Solutions

PAH Care Model Provides a Road Map for Rare Disease Treatment

The Shields Health Solutions care model for helping pharmacies and providers treat patients with pulmonary arterial hypertension (PAH) integrates a patient’s entire care team, and can be adopted to successfully…